Menu

Testing Endurance

Researchers follow 44 ultramarathon runners in a race across Europe to track the body's response to extreme physical challenge.

Jul 26, 2012
Hayley Dunning

During the Trans Europe Foot Race, runners cover more than 4,487 kilometers (2,788 miles) from southern Italy to North Cape, Norway. For the 2009 race, 44 of those runners submitted to daily health examinations, including MRI scans with a mobile scanner, ice-water pain tests, and blood and urine analyses. The project, detailed last week (July 19) in BioMed Medicine, was divided into four modules:

  • Musculoskeletal system: to investigate potential damage to joints, bones, and soft tissues in the legs
  • Brain, mind, and pain perception: to investigate changes in the volume of the brain, damage caused by lesions, pain perception, and mental stress
  • Cardiovascular system: to assess the effects of stress on the heart and arterial wall strength
  • Body composition: to track changes in muscle mass and body fat
While the huge resulting data set is still being looked at from every angle, the researchers have released some preliminary results. Of studied runners that didn't finish the race, the most common reason was inflammation of the leg tissues due to overuse. Two runners fractured bones, but because of their high pain tolerance, they ran over 200 more kilometers before giving up. Some runners who experienced leg inflammation were able to continue running, and it eventually cleared up.

The data will be used to assess the course of breakdown and regeneration in such injuries, as well as provide insights into the susceptibility to injury between individuals. By looking into the brain, the researchers also hope to investigate the hormonal influence resulting from endurance exercise.

"This pioneering study will assess the impact of extreme endurance on human physiology," wrote Andrew Murray and Ricardo Costa in an editorial for BioMed Medicine. "The results will be of interest not only to endurance runners, but to anyone interested in the limits of human performance."

Correction (July 30, 2012): This story has been updated from its original version to correctly reflect the journal name as BioMed Medicine, not BioMed Central Medicine. The Scientist regrets the error.

September 2018

The Muscle Issue

The dynamic tissue reveals its secrets

Marketplace

Sponsored Product Updates

StemExpress LeukopakâNow Available in Frozen Format

StemExpress LeukopakâNow Available in Frozen Format

StemExpress, a Folsom, California based leading supplier of human biospecimens, announces the release of frozen Peripheral Blood Leukopaks. Leukopaks provide an enriched source of peripheral blood mononuclear cells (PBMCs) with low granulocyte and red blood cells that can be used in a variety of downstream cell-based applications.

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

Vector Laboratories, a leader in the development and manufacture of labeling and detection reagents for biomedical research, introduces VECTASHIELD® Vibrance™ – antifade mounting media that delivers significant improvements to the immunofluorescence workflow.

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Download this white paper from Bertin Technologies to learn how to extract and analyze lipid samples from various models!

Bio-Rad Launches CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin for Process Protein Purification

Bio-Rad Launches CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin for Process Protein Purification

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced the launch of two new chromatography media for process protein purification: CHT Ceramic Hydroxyapatite XT Media and Nuvia HP-Q Resin.